| Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine C Borgna-Pignatti, S Rugolotto, P De Stefano, H Zhao, MD Cappellini, ... haematologica 89 (10), 1187-1193, 2004 | 1551 | 2004 |
| A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia MD Cappellini, A Cohen, A Piga, M Bejaoui, S Perrotta, L Agaoglu, ... Blood 107 (9), 3455-3462, 2006 | 936 | 2006 |
| Survival and causes of death in thalassaemia major MG Zurlo, P De Stefano, C Borgna-Pignatti, A Di Palma, C Melevendi, ... The Lancet 334 (8653), 27-30, 1989 | 812 | 1989 |
| Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis DJ Pennell, V Berdoukas, M Karagiorga, V Ladis, A Piga, A Aessopos, ... Blood 107 (9), 3738-3744, 2006 | 607 | 2006 |
| Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver E Bugianesi, P Manzini, S D'Antico, E Vanni, F Longo, N Leone, ... Hepatology 39 (1), 179-187, 2004 | 598 | 2004 |
| Survival and complications in thalassemia C BORGNA‐PIGNATTI, MD Cappellini, P De Stefano, GC Del Vecchio, ... Annals of the New York Academy of Sciences 1054 (1), 40-47, 2005 | 561 | 2005 |
| Results of long-term iron-chelating therapy V Gabutti, A Piga Acta Haematologica 95 (1), 26-36, 1996 | 526 | 1996 |
| Cardiac morbidity and mortality in deferoxamine-or deferiprone-treated patients with thalassemia major C Borgna-Pignatti, MD Cappellini, P De Stefano, GC Del Vecchio, ... Blood 107 (9), 3733-3737, 2006 | 510 | 2006 |
| Survival and disease complications in thalassemia major C BORGNA‐PIGNATTI, S Rugolotto, P De Stefano, A Piga, F Di Gregorio, ... Annals of the New York Academy of Sciences 850 (1), 227-231, 1998 | 475 | 1998 |
| Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait K Ayi, F Turrini, A Piga, P Arese Blood 104 (10), 3364-3371, 2004 | 429 | 2004 |
| Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association DJ Pennell, JE Udelson, AE Arai, B Bozkurt, AR Cohen, R Galanello, ... Circulation 128 (3), 281-308, 2013 | 398 | 2013 |
| Seventy-five genetic loci influencing the human red blood cell P Van Der Harst, W Zhang, I Mateo Leach, A Rendon, N Verweij, J Sehmi, ... Nature 492 (7429), 369-375, 2012 | 390 | 2012 |
| Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone AR Cohen, R Galanello, A Piga, V De Sanctis, F Tricta Blood 102 (5), 1583-1587, 2003 | 371 | 2003 |
| Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with … A Piga, R Galanello, GL Forni, MD Cappellini, R Origa, A Zappu, ... haematologica 91 (7), 873-880, 2006 | 370 | 2006 |
| Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis A Piga, C Gaglioti, E Fogliacco, F Tricta Haematologica 88 (5), 489-496, 2003 | 364 | 2003 |
| Guidelines for the clinical management of thalassaemia MD Cappellini, A Cohen, A Eleftheriou, A Piga, J Porter, A Taher | 345 | 2013 |
| Relative response of patients with myelodysplastic syndromes and other transfusion‐dependent anaemias to deferasirox (ICL670): a 1‐yr prospective study J Porter, R Galanello, G Saglio, EJ Neufeld, E Vichinsky, MD Cappellini, ... European journal of haematology 80 (2), 168-176, 2008 | 315 | 2008 |
| New mutations inactivating transferrin receptor 2 in hemochromatosis type 3 A Roetto, A Totaro, A Piperno, A Piga, F Longo, G Garozzo, A Calı, ... Blood, The Journal of the American Society of Hematology 97 (9), 2555-2560, 2001 | 308 | 2001 |
| The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients A Ceci, P Baiardi, M Felisi, MD Cappellini, V Carnelli, V De Sanctis, ... British journal of haematology 118 (1), 330-336, 2002 | 298 | 2002 |
| Safety profile of the oral iron chelator deferiprone: a multicentre study Galanello, Piga, DiPalma, Vullo, Tricta British journal of haematology 108 (2), 305-312, 2000 | 293 | 2000 |
